Toll-Like Receptors/TNF-
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
08
2021
revised:
17
11
2021
accepted:
24
11
2021
entrez:
15
4
2022
pubmed:
16
4
2022
medline:
19
4
2022
Statut:
epublish
Résumé
Recurrent myocardial infarction is associated with increased mortality. Risk and predictive factors of recurrent myocardial infarction in elderly patients after coronary stenting are not well known. This research sought to investigate the effects of proinflammatory cytokines and toll-like receptor on recurrent myocardial infarction after coronary stenting in elderly patients. We measured the levels of toll-like receptor 2 (TLR2), toll-like receptor 3 (TLR3), toll-like receptor 4 (TLR4), tumor necrosis factor- Levels of TLR2, TLR3, TLR4, TNF- The increase levels of proinflammatory cytokines and toll-like receptors were associated with recurrent myocardial infarction after coronary stenting. Increased expressions of proinflammatory cytokines and toll-like receptors may be clinically useful biomarkers for predicting recurrent myocardial infarction in the elderly patients after coronary stent implantation.
Sections du résumé
Background
UNASSIGNED
Recurrent myocardial infarction is associated with increased mortality. Risk and predictive factors of recurrent myocardial infarction in elderly patients after coronary stenting are not well known. This research sought to investigate the effects of proinflammatory cytokines and toll-like receptor on recurrent myocardial infarction after coronary stenting in elderly patients.
Methods
UNASSIGNED
We measured the levels of toll-like receptor 2 (TLR2), toll-like receptor 3 (TLR3), toll-like receptor 4 (TLR4), tumor necrosis factor-
Results
UNASSIGNED
Levels of TLR2, TLR3, TLR4, TNF-
Conclusion
UNASSIGNED
The increase levels of proinflammatory cytokines and toll-like receptors were associated with recurrent myocardial infarction after coronary stenting. Increased expressions of proinflammatory cytokines and toll-like receptors may be clinically useful biomarkers for predicting recurrent myocardial infarction in the elderly patients after coronary stent implantation.
Identifiants
pubmed: 35425840
doi: 10.1155/2022/1280350
pmc: PMC9005286
doi:
Substances chimiques
Cytokines
0
Toll-Like Receptor 2
0
Toll-Like Receptor 3
0
Toll-Like Receptor 4
0
Toll-Like Receptors
0
Tumor Necrosis Factor-alpha
0
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1280350Informations de copyright
Copyright © 2022 Xia Li et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests regarding the publication of this article.
Références
Mol Med Rep. 2022 Jan;25(1):
pubmed: 34738620
Tissue Eng Part B Rev. 2018 Feb;24(1):1-24
pubmed: 28548628
Clin Exp Immunol. 2006 Feb;143(2):269-73
pubmed: 16412050
Cells. 2020 May 14;9(5):
pubmed: 32422978
Sci Rep. 2017 Jan 06;7:39945
pubmed: 28059114
Int J Mol Sci. 2014 Dec 29;16(1):535-46
pubmed: 25551602
J Geriatr Cardiol. 2015 May;12(3):305-12
pubmed: 26089856
Allergy Asthma Clin Immunol. 2016 Apr 27;12:17
pubmed: 27127523
Atherosclerosis. 2018 May;272:41-46
pubmed: 29547707
Sci Rep. 2017 Sep 14;7(1):11508
pubmed: 28912506
Immunol Lett. 2014 Sep;161(1):81-8
pubmed: 24845156
Biomed Res Int. 2013;2013:845037
pubmed: 23484163
Cardiovasc Res. 2013 Jul 15;99(2):364-73
pubmed: 23417039
Int J Mol Sci. 2020 Jan 24;21(3):
pubmed: 31991572
Int Heart J. 2017 Apr 6;58(2):245-249
pubmed: 28367848
J Vasc Res. 2017;54(3):156-169
pubmed: 28478461
Atherosclerosis. 2007 May;192(1):25-32
pubmed: 16857205
Circulation. 2002 Jun 25;105(25):2981-5
pubmed: 12081991
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75
pubmed: 12588755
Circ Res. 2001 Jul 6;89(1):E1-7
pubmed: 11440984
Am J Hypertens. 2017 Mar 1;30(3):313-318
pubmed: 27927628
BMC Cancer. 2010 Dec 03;10:665
pubmed: 21129170
World J Gastroenterol. 2008 Sep 7;14(33):5115-24
pubmed: 18777587
Immunol Res. 2016 Apr;64(2):424-30
pubmed: 26318748
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1168-73
pubmed: 15831811
Circ J. 2008 May;72(5):832-8
pubmed: 18441467
Cell Mol Immunol. 2017 Jan;14(1):107-117
pubmed: 27374795
J Am Coll Cardiol. 2000 Oct;36(4):1210-6
pubmed: 11028472
ACS Appl Mater Interfaces. 2017 Aug 23;9(33):27522-27532
pubmed: 28748694
Eur Heart J. 2004 Jun;25(12):1003-8
pubmed: 15191769
Hypertens Res. 2007 Feb;30(2):133-41
pubmed: 17460383
Neurobiol Dis. 2012 Mar;45(3):1077-85
pubmed: 22198574
Circulation. 2005 Jun 7;111(22):2981-7
pubmed: 15927972
Cell Physiol Biochem. 2018;51(3):1051-1068
pubmed: 30476912
J Am Coll Cardiol. 2004 Aug 18;44(4):733-9
pubmed: 15312851
Med Glas (Zenica). 2020 Aug 1;17(2):414-419
pubmed: 32662609
Circulation. 2001 Jun 19;103(24):2885-90
pubmed: 11413075
Brain Res Bull. 2018 Jun;140:233-242
pubmed: 29751031
Int Heart J. 2007 Sep;48(5):553-67
pubmed: 17998765
Kidney Blood Press Res. 2018;43(3):701-718
pubmed: 29763891
Basic Res Cardiol. 2008 Sep;103(5):398-406
pubmed: 18600364
J Am Heart Assoc. 2018 Apr 23;7(9):
pubmed: 29686027
Lipids Health Dis. 2018 Jul 27;17(1):176
pubmed: 30053815
Gene Ther. 2009 May;16(5):629-34
pubmed: 19212427
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):362-376
pubmed: 31899965
Cardiovasc Res. 2005 Apr 1;66(1):162-9
pubmed: 15769459
Int J Cardiol. 2013 Oct 3;168(3):2453-61
pubmed: 23561917
Cardiovasc Res. 2008 Aug 1;79(3):360-76
pubmed: 18487233
Gut. 2006 Mar;55(3):426-31
pubmed: 16474109
J Atheroscler Thromb. 2005;12(1):53-60
pubmed: 15725697
Int J Cardiol. 2006 Oct 26;113(1):34-8
pubmed: 16325284
Eur Heart J. 2004 Oct;25(19):1679-87
pubmed: 15451145
J Atheroscler Thromb. 2018 Mar 1;25(3):269-280
pubmed: 28931782
J Neurosci Res. 2009 May 15;87(7):1565-72
pubmed: 19115402
Biochem Biophys Res Commun. 2015 Aug 21;464(2):453-8
pubmed: 26116774